NVST

EnvistaB

NYSE / Health Care Equipment & Services

At close

2026-07-22

View Chart

AI scenario view

RankAlpha Sentiment AI

B+

Bull case

20%

Probability

Target price

$30.00

+12.9% vs current

Most likely

Base case

60%

Probability

Target price

$24.54

-7.7% vs current

B-

Bear case

20%

Probability

Target price

$14.22

-46.5% vs current

AI sentiment snapshot

Latest data as of 2026-02-09

AI commentary

Sentiment is mixed-to-cautious: the consensus median is below the broker_last anchor while a few brokers maintain $30+ targets. Near-term direction will hinge on the upcoming quarterly report and post-earnings analyst reactions; longer-term conviction depends on product execution and consumables growth.

RankAlpha Sentiment AI - 2026-02-09

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-05-10catalystNext quarterly earnings report (estimated)High impact

Quarterly earnings and management guidance are the most likely near-term re-rating events; analysts' consensus targets imply downside vs the broker_last anchor which could drive revision risk after results [#SERP-2]. Date follows conservative short-horizon estimate per schema rules.

2026-06-09eventPost-earnings analyst target revisionsHigh impact

Broker and sell-side target changes (e.g., recent Baird update) commonly arrive after reported results and can alter sentiment materially; assume revisions materialize within ~30 days of results [#SERP-9].

2027-02-09catalystProduct pipeline execution and market-share recoveryHigh impact

Sustained upside would require successful commercialization of product initiatives and recovery in dental procedure volumes; this is a multiyear driver that aligns with surveyed analyst upside but depends on execution [#SERP-6].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-02-09 • Updated nightlySource: Internal modelMethodology